CIM Investment Management’s Editas Medicine EDIT Stock Holding History

CIM Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,251	Closed	-$216K	–	307
2021 Q3	$216K	Hold	5,251	–	–	0.07%	268
2021 Q2	$297K	Buy	+5,251	New	+$194K	0.09%	209
2019 Q2	–	Sell	-18,629	Closed	-$455K	–	322
2019 Q1	$455K	Sell	18,629 -158	-0.8%	-$3.58K	0.18%	144
2018 Q4	$427K	Hold	18,787	–	–	0.19%	132
2018 Q3	$598K	Hold	18,787	–	–	0.21%	107
2018 Q2	$673K	Hold	18,787	–	–	0.23%	103
2018 Q1	$623K	Sell	18,787 -6,000	-24%	-$214K	0.21%	125
2017 Q4	$762K	Sell	24,787 -72	-0.3%	-$1.81K	0.26%	99
2017 Q3	$597K	Hold	24,859	–	–	0.22%	119
2017 Q2	$417K	Sell	24,859 -757	-3%	-$13.6K	0.15%	194
2017 Q1	$572K	Buy	+25,616	New	+$531K	0.2%	135
2016 Q3	–	Sell	-9,366	Closed	-$229K	–	348
2016 Q2	$229K	Buy	+9,366	New	+$316K	0.09%	261

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIM Investment Management's EDIT Position: Q4 2021 in Review

CIM Investment Management sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 5,251 shares — an estimated $216K sold.

CIM Investment Management first reported a position in EDIT in Q2 2016 and held it in 12 quarters. The position peaked at $762K in Q4 2017. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

CIM Investment Management reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
CIM Investment Management sold 5,251 Editas Medicine shares in Q4 2021, an estimated $216K.
CIM Investment Management first reported a position in Editas Medicine in Q2 2016 and held it in 12 quarters.
CIM Investment Management's Editas Medicine position peaked at $762K in Q4 2017.
305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on CIM Investment Management's 13F filing for Q4 2021, filed 2 Feb 2022.